NAD+-consuming enzymes in the regulation of lung immune responses

Open Immunology Journal

Volumn 2, Issue 1, 2009, Pages 42-51

  Legutko, Agnieszka ^a   Lekeux, Pierre ^a   Bureau, Fabrice ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ADENOSINE DIPHOSPHATE RIBOSE CYCLASE; ADENOSINE DIPHOSPHATE RIBOSE SYNTHASE; ART1 ENZYME; ART2 ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP 1 ENZYME; SIRTUIN; SYNTHETASE; UNCLASSIFIED DRUG;

AGING; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CELL DEATH; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; ENERGY METABOLISM; HUMAN; IMMUNE RESPONSE; LUNG FIBROSIS; MITOCHONDRION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEPTIC SHOCK;

EID: 77953471132     PISSN: None     EISSN: 18742262     Source Type: Journal    
DOI: 10.2174/1874226200902010042     Document Type: Review

References (118)

1. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxid Redox Signal 2008; 10: 179-206.
2. Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemichannels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J 2000; 15(1): 10-12
3. Haag F, Adriouch S, Braß A, et al. Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal 2007; 3: 71-81.
4. Adriouch S, Hubert S, Pechberty S, Koch-Nolte F, Haag F, Seman M. NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J Immunol 2007; 179: 186-194 (Pubitemid 46986533)
5. Liu Z-X, Azhipa O, Okamoto S, Govindarajan S, Dennert G. Extracellular nicotinamide adenine dinucleotide induces T cell apoptosis in vivo and in vitro. J Immunol 2001; 167: 4942-4947 (Pubitemid 33009724)
6. Seman M, Adriouch S, Scheuplein F, et al. NAD-Induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 2003; 19: 571-582
7. Haag F, Freese D, Scheublein F, et al. T cells of different developmental stages differ in sensitivity to apoptosis induced by extracellular NAD. Dev Immunol 2002; 9: 197-202.
8. Aswad F, Kawamura H, Dennert G. High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 2005; 175: 3075-3083 (Pubitemid 41170527)
9. Chambon P, Weill J, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 1963; 11: 39-43.
10. Gill D, Pappenheimer AJ, Brown R, Kurnick J. Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts. J Exp Med 1969; 129: 1-21.
11. Okazaki IJ, Moss J. Characterization of glycosylphosphatidylinositiol- anchored, secreted, and intracellular vertebrate mono-ADPribosyltransferases. Annu Rev Nutr 1999; 19: 485-509. (Pubitemid 29380614)
12. Amé J-C, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays 2004; 26: 882-893
13. Koch-Nolte F, Kernstock S, Mueller-Dieckmann C, Weiss M, Haag F. Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases. Front Biosci 2008; 13: 6716-6729
14. Okazaki I, Moss J. Mono-ADP-ribosylation: a reversible posttranslational modification of proteins. Adv Pharmacol 1996; 35: 247-280
15. Koch-Nolte F, Adriouch S, Bannas P, et al. ADP-ribosylation of membrane proteins: Unveiling the secrets of a crucial regulatory mechanism in mammalian cells. Ann Med 2006; 38: 188-199
16. Hassa PO, Haenni SS, Elser M, Hottiger MO. Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol Mol Biol Rev 2006; 70: 789-829.
17. Beneke S. Poly(ADP-ribose) polymerase activity in different pathologies - The link to inflammation and infarction. Exp Gerontol 2008; 43: 605-614
18. Glowacki G, Braren R, Firner K, et al. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci 2002; 11: 1657-1670
19. Glowacki G, Braren R, Cetkovic-Cvrlje M, Leiter EH, Haag F, Koch-Nolte F. Structure, chromosomal localization, and expression of the gene for mouse ecto-mono (ADP-ribosyl)transferase ART5. Gene 2001; 275: 267-277 (Pubitemid 32918356)
20. Seman M, Adriouch S, Haag F, Koch-Nolte F. Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr Med Chem 2004; 11: 857-872
21. Zolkiewska A, Moss J. Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. J Biol Chem 1993; 268: 25273-25276 (Pubitemid 2004130)
22. Braren R, Glowacki G, Nissen M, Haag F, Koch-Nolte F. Molecular characterization and expression of the gene for mouse NAD+:arginine ecto-mono(ADP-ribosyl)transferase, Art1. Biochem J 1998; 336: 561-568 (Pubitemid 29008013)
23. Balducci E, Horiba K, Usuki J, Park M, Ferrans VJ, Moss J. Selective expression of RT6 superfamily in human bronchial epithelial cells. Am J Respir Cell Mol Biol 1999; 21: 337-346 (Pubitemid 129517188)
24. Donnelly LE, Rendell NB, Murray S, et al. Arginine-specific mono(ADP-ribosyl)transferase activity on the surface of human polymorphonuclear neutrophil leucocytes. Biochem J 1996; 315: 635-641
25. Allport J, Donnelly L, Hayes B, et al. Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin. Br J Pharmacol 1996; 118: 1111-1118
26. Paone G, Wada A, Stevens LA, et al. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc Natl Acad Sci USA 2002; 99: 8231-8235
27. Paone G, Stevens LA, Levine RL, et al. ADP-ribosyltransferase-specific modification of human neutrophil peptide-1. J Biol Chem 2006; 281: 17054-17060
28. Del Vecchio M, Balducci E. Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells. Mol Cell Biochem 2008; 310: 77-83.
29. Balducci E, Micossi LG, Soldaini E, Rappuoli R. Expression and selective up-regulation of toxin-related mono ADP-ribosyltransferases by pathogen-associated molecular patterns in alveolar epithelial cells. FEBS Lett 2007; 581: 4199-4204
30. Haag F, Koch-Nolte F, Kühl M, Lorenzen S, Thiele H-G. Premature stop codons inactivate the RT6 genes of the human and chimpanzee species. J Mol Biol 1994; 243: 537-546 (Pubitemid 24336998)
31. Koch-Nolte F, Duffy T, Nissen M, et al. A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: Subset distribution, inbred strain variation, and modulation upon T cell activation. J Immunol 1999; 163: 6014-6022
32. Hara N, Badruzzaman M, Sugae T, Shimoyama M, Tsuchiya M. Mouse Rt6.1 is a thiol-dependent arginine-specific ADP-ribosyltransferase. Eur J Biochem 1999; 259: 289-294
33. Adriouch S, Ohlrogge W, Haag F, Koch-Nolte F, Seman M. Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: requirement for mono(ADP-ribosyl)transferase 2 and a downstream effector. J Immunol 2001; 167: 196-203. (Pubitemid 32567778)
34. Nemoto E, Yu Y, Dennert G. Cell surface ADP-ribosyltransferase regulates lymphocyte function- associated molecule-1 (LFA-1) function in T cells. J Immunol 1996; 157: 3341-3349 (Pubitemid 126449145)
35. Okamoto S, Azhipa O, Yu Y, Russo E, Dennert G. Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J Immunol 1998; 160: 4190-4198 (Pubitemid 28217272)
36. Scheuplein F, Adriouch S, Glowacki G, Haag F, Seman M, Koch-Nolte F. Triggering of T-cell apoptosis by toxin-related ecto-ADP-ribosyltransferase ART2. Ann N Y Acad Sci 2003; 1010: 296-299
37. Ohlrogge W, Haag F, Lohler J, et al. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Mol Cell Biol 2002; 22: 7535-7542
38. Kahl S, Nissen M, Girisch R, et al. Metalloprotease-mediated shedding of enzymatically active mouse ecto-ADP-ribosyltransferase ART2.2 upon T cell activation. J Immunol 2000; 165: 4463-4469
39. Bortel R, Waite D, Whalen B, et al. Levels of Art2+ cells but not soluble Art2 protein correlate with expression of autoimmune diabetes in the BB rat. Autoimmunity 2001; 33: 199-211.
40. Rigby M, Bortell R, Greiner D, et al. The rat T-cell surface protein RT6 is associated with src family tyrosine kinases and generates an activation signal. Diabetes 1996; 45: 1419-1426
41. Todd DJ, Forsberg EM, Greiner DL, Mordes JP, Rossini AA, Bortell R. Deficiencies in gut NK cell number and function precede diabetes onset in BB rats. J Immunol 2004; 172: 5356-5362 (Pubitemid 38542034)
42. Kawamura H, Aswad F, Minagawa M, Govindarajan S, Dennert G. P2X7 receptors regulate NKT cells in autoimmune hepatitis. J Immunol 2006; 176: 2152-2160 (Pubitemid 43201662)
43. Hong SBA, Seman M, Haag F, Koch-Nolte F, Dubyak GR. Lipopolysaccharide, IFN-gamma, and IFN-beta induce expression of the thiol-sensitive ART2.1 Ecto-ADP-ribosyltransferase in murine macrophages. J Immunol 2007; 179: 6215-6227
44. Shieh WM, Ame J-C, Wilson MV, et al. Poly (ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J Biol Chem 1998; 273: 30069-30072
45. Kraus WL. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol 2008; 20: 294-302.
46. van Wijk SJL, Hageman GJ. Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic Biol Med 2005; 39: 81-90.
47. Moroni F. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Curr Opin Pharmacol 2008; 8: 96-103.
48. Kauppinen TM. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease. Neurochem Int 2007; 50: 954-958 (Pubitemid 46962810)
49. Pacher P, Szabó C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol 2008; 173: 2-13.
50. Pacher P, Szabó C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 2007; 25: 235-260
51. Miwa M, Masutani M. PolyADP-ribosylation and cancer. Cancer Sci 2007; 98: 1528-1535
52. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-1553 (Pubitemid 35239308)
53. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 2005; 52: 72-82.
54. Virág L. Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharmacol Res 2005; 52: 83-92.
55. Virág L, Szabó C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
56. Woolley SM, Farivar AS, Naidu BV, et al. Role of Poly (ADP) ribose synthetase in lung ischemia - reperfusion injury. J Heart Lung Transplant 2004; 23: 1290-1296
57. Koksel O, Yildirim C, Cinel L, et al. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats. Pharmacol Res 2005; 51: 453-462
58. Farivar AS, Woolley SM, Fraga CH, et al. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury. Ann Thorac Surg 2004; 77: 1938-1943.
59. Szabó G, Soós P, Mandera S, et al. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation. Shock 2004; 21: 426-432
60. Farivar AS, Woolley SM, Naidu BV, et al. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts. J Heart Lung Transplant 2004; 23: 993-1002.
61. Su CF, Liu DD, Kao SJ, Chen HI. Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion. Eur Respir J 2007; 30: 199-204.
62. Pagano A, Pitteloud C, Reverdin C, Metrailler-Ruchonnet I, Donati Y, Barazzone Argiroffo C. Poly(ADP-ribose)polymerase activation mediates lung epithelial cell death in vitro but is not essential in hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 2005; 33: 555-564
63. Pagano A, Metrailler-Ruchonnet I, Aurrand-Lions M, Lucattelli M, Donati Y, Argiroffo CB. Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxiainduced lung damage. Am J Physiol Lung Cell Mol Physiol 2007; 293: 619-629 (Pubitemid 47358824)
64. Kim J, Suk M, Yoon D, et al. Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury. Crit Care 2008; 12: R108.
65. Vaschetto R, Kuiper JW, Chiang, et al. Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury. Anesthesiology 2008; 108: 261-268
66. Genovese T, Mazzon E, Di Paola R, et al. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. J Pharmacol Exp Ther 2005; 313: 529-538
67. Horváth EM, Benko R, Gero D, Kiss L, Szabó C. Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia. Life Sci 2008; 82: 205-209
68. Tasatargil A, Aksoy NH, Dalaklioglu S, Sadan G. Poly (ADP-ribose) polymerase as a potential target for the treatment of acute renal injury caused by lipopolysaccharide. Ren Fail 2008; 30: 115-120
69. Liaudet L, Pacher P, Mabley JG, et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372-377
70. Kao S, Liu D, Su C, Chen H. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin. J Cardiovasc Pharmacol 2007; 50: 333-342 (Pubitemid 47428984)
71. Murakami K, Enkhbaatar P, Shimoda K, et al. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004; 21: 126-133
72. Kiefmann R, Heckel K, Doerger M, et al. Role of PARP on iNOS pathway during endotoxin-induced acute lung injury. Intensive Care Med 2004; 30: 1421-1431
73. Veres B, Radnai B, Gallyas F Jr, et al. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 2004; 310: 247-255
74. Hageman GJ, Larik I, Pennings H-J, Haenen GR, Wouters EF, Bast A. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 2003; 35: 140-148
75. Moonen HJ, Geraets L, Vaarhorst A, Bast A, Wouters EF, Hageman GJ. Theophylline prevents NAD+ depletion via PARP-1 inhibition in human pulmonary epithelial cells. Biochem Biophys Res Commun 2005; 338: 1805-1810
76. Espinoza LA, Smulson ME, Chen Z. Prolonged poly(ADP-ribose) polymerase-1 activity regulates JP-8-induced sustained cytokine expression in alveolar macrophages. Free Radic Biol Med 2007; 42: 1430-1440 (Pubitemid 46467278)
77. Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME. Gene knockout or pharmacological inhibition of poly(ADP-Ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 2003; 28: 322-329 (Pubitemid 36238009)
78. Virág L, Bai P, Bak I, et al. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monitor 2004; 10: 77-83.
79. Suzuki Y, Masini E, Mazzocca C, et al. Inhibition of poly(ADP-Ribose) polymerase prevents allergen-induced asthma-like reaction in sensitized guinea pigs. J Pharmacol Exp Ther 2004; 311: 1241-1248
80. Oumouna M, Datta R, Oumouna-Benachour K, et al. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: A potential specific effect on IL-5. J Immunol 2006; 177: 6489-6496
81. Naura AS, Hans CP, Zerfaoui M, et al. Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation. Clin Exp Allergy 2008; 38: 839-846
82. Naura AS, Datta R, Hans CP, et al. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J 2009; 33(2): 252-262
83. Singh D, Richards D, Knowles RG, et al. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med 2007; 176: 988-993
84. Malavasi F, Deaglio S, Ferrero E, et al. CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol Med 2006; 12: 334-341
85. Fliegert R, Gasser A, Guse AH. Regulation of calcium signalling by adenine-based second messengers. Biochem Soc Trans 2007; 35: 109-114
86. Malavasi F, Deaglio S, Funaro A, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 2008; 88: 841-886
87. Lund F. Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity. Mol Med 2006; 12: 328-333 (Pubitemid 46489828)
88. Deshpande DA, White TA, Guedes AGP, et al. Altered Airway Responsiveness in CD38-Deficient Mice. Am J Respir Cell Mol Biol 2005; 32: 149-156
89. Gally F, Hartney JM, Janssen WJ, Perraud A-L. CD38 plays a dual role in allergen-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol 2008; (In press).
90. Jain D, Keslacy S, Tliba O, et al. Essential role of IFN[beta] and CD38 in TNF[alpha]-induced airway smooth muscle hyperresponsiveness. Immunobiology 2008; 213: 499-509.
91. Guedes AGP, Paulin J, Rivero-Nava L, Kita H, Lund FE, Kannan MS. CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge. Am J Physiol Lung Cell Mol Physiol 2006; 291: 1286-1293 (Pubitemid 44904535)
92. Deshpande DA, White TA, Dogan S, Walseth TF, Panettieri RA, Kannan MS. CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005; 288: 773-788 (Pubitemid 40547901)
93. Deshpande DA, Dogan S, Walseth TF, et al. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 2004; 31: 36-42.
94. Deshpande DA, Walseth TF, Panettieri RA, Kannan MS. CD38-cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyperresponsiveness. FASEB J 2003; 17: 452-454
95. Sieck GC, White TA, Thompson MA, Pabelick CM, Wylam ME, Prakash YS. Regulation of store-operated Ca2+ entry by CD38 in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2008; 294: 378-385
96. Kang B-N, Tirumurugaan KG, Deshpande DA, et al. Transcriptional regulation of CD38 expression by tumor necrosis factor-{alpha} in human airway smooth muscle cells: role of NF-{kappa}B and sensitivity to glucocorticoids. FASEB J 2006; 20: 1000-1002
97. Tirumurugaan KG, Jude JA, Kang BN, Panettieri RA, Walseth TF, Kannan MS. TNF-{alpha} induced CD38 expression in human airway smooth muscle cells: Role of MAP kinases and transcription factors NF-{kappa}B and AP-1. Am J Physiol Lung Cell Mol Physiol 2007; 292: 1385-1395
98. Klar AJS, Fogel S, Macleod K. MAR1- a regulator of the HMa and HMalpha loci in saccharomyces cerevisiae. Genetics 1979; 93: 37-50.
99. Rine J, Herskowitz I. Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. Genetics 1987; 116: 9-22.
100. Braunstein M, Rose AB, Holmes SG, Allis CD, Broach JR. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev 1993; 7: 592-604.
101. Denu JM. The Sir2 family of protein deacetylases. Curr Opin Chem Biol 2005; 9: 431-440
102. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999; 260: 273-279 (Pubitemid 29351819)
103. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273: 793-798
104. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005; 16: 4623-4635
105. Vaziri H, Dessain SK, Eaton EN, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-159
106. Motta MC, Divecha N, Lemieux M, et al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551-563
107. Bouras T, Fu M, Sauve AA, et al. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 2005; 280(11): 10264-10276
108. Yeung F, Hoberg J, Ramsey C, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-2380
109. Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations through the PGC-1[alpha] and SIRT1 pathways. FEBS Lett 2008; 582: 46-53.
110. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation? Bioessays 2008; 30: 939-942
111. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA 2008; 105: 9793-9798
112. Gao Z, Ye J. Inhibition of transcriptional activity of c-JUN by SIRT1. Biochem Biophys Res Commun 2008; 376: 793-796
113. Rajendrasozhan S, Yang S-R, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 861-870
114. McBurney MW, Yang X, Jardine K, et al. The mammalian SIR2{alpha} protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 2003; 23: 38-54.
115. Yang S-R, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-{kappa}B in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292: 567-576
116. Aksoy P, Escande C, White TA, et al. Regulation of SIRT 1 mediated NAD dependent deacetylation: A novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun 2006; 349: 353-359
117. Krebs C, Adriouch S, Braasch F, et al. CD38 controls ADPribosyltransferase- 2-catalyzed ADP-ribosylation of T cell surface proteins. J Immunol 2005; 174: 3298-3305
118. Zhang J. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? Bioessays 2003; 25: 808-814